HTC-19 Profile: What’s Cooking in the mRNA Lab?
Jonathan Maurer of the University of Geneva discusses his work with Sanofi and Waters – and why good analytical science has a lot in common with good cooking
False
Jonathan Maurer of the University of Geneva discusses his work with Sanofi and Waters – and why good analytical science has a lot in common with good cooking
The researcher specializes in analytical challenges related to next-generation mRNA-LNP drug products in collaboration with Sanofi and Waters.
Their work focuses on assessing mRNA integrity, encapsulation, and lipid characteristics using advanced analytical methods.
The researcher emphasizes the importance of collaboration between academia and industry to improve analytical tools for future medicines.
Their upcoming talk at HTC-19 will challenge traditional assumptions about HILIC retention mechanisms for oligonucleotides.
Future research aims to analyze lipid nanoparticle carriers and their interactions with mRNA using machine learning strategies.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

False
False
December 12, 2024
2 min read
How a framework for controlling molecular reactions at the atomic scale has potential implications for nanotechnology, pharmaceutical synthesis, and clean energy research
October 1, 2024
10 min read
Charge-detection mass spectrometry (CD-MS) has extended the range of MS to gigadalton-sized viruses and polymers; and with a commercial instrument in development and exciting new applications in complex protein mixtures, maturity beckons
October 1, 2024
1 min read
Researchers develop an NMR method to distinguish between enantiomers without the need for chiral agents
October 2, 2024
2 min read
Researchers combine tissue imaging with proteomics to shed light on the neurotoxic effects associated with HIV medication Efavirenz treatment
Affiliations:
Specialties:
Areas of Expertise:
False